
A Canadian-made generic Ozempic is poised to enter the market
Vimy Pharmaceuticals, which announced on August 6 plans to go public, will produce the superstar drug in Edmonton
We use Google Analytics to see which stories get read. It’s always on because it’s how we learn what readers want more of, and it doesn’t use advertising cookies. Third-party tracking for advertising is optional and stays off unless you accept it. Learn more.
Christina Frangou is an independent journalist in Calgary who specializes in covering health. She is a member of the Canadian Institutes of Health Research Standing Committee on Science.

Vimy Pharmaceuticals, which announced on August 6 plans to go public, will produce the superstar drug in Edmonton

The CEO of Toronto’s University Health Network has a bold proposal: Canadian world domination in clinical enterprises

Dr. Prakesh Shah has revolutionized neonatal care by instituting surprisingly simple fixes

Vimy Pharmaceuticals, which announced on August 6 plans to go public, will produce the superstar drug in Edmonton

Dr. Prakesh Shah has revolutionized neonatal care by instituting surprisingly simple fixes

The CEO of Toronto’s University Health Network has a bold proposal: Canadian world domination in clinical enterprises

Vimy Pharmaceuticals, which announced on August 6 plans to go public, will produce the superstar drug in Edmonton

The CEO of Toronto’s University Health Network has a bold proposal: Canadian world domination in clinical enterprises

Dr. Prakesh Shah has revolutionized neonatal care by instituting surprisingly simple fixes